VISTIN PHARMA ASA: årsregnskap 2015 vs 2014
Cash halved-plus, fresh owner capital
approved 2016-04-27; registry 2016-06-25; journal 2016 566012
Summary
What changed
Comparing Årsregnskap 2015 with 2014 for VISTIN PHARMA ASA. Revenue 0 NOK → 227.9k NOK. Equity 0 NOK → 170.52m NOK.
On the constructive side: revenue rose; equity strengthened; owners injected capital. Pressures included: cash fell.
Also worth watching: cogs fell; book investments changed. All figures are taken from the published annual accounts for VISTIN PHARMA ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 0 NOK to 227.9k NOK. Calculated
-
↑
Equity strengthened
Book equity 0 NOK → 170.52m NOK. Calculated
-
↑
Owners injected capital
Paid-in equity rose 0 NOK → 170.5k NOK (+170.5k NOK). Reported fact
What deteriorated
-
↓
Cash fell
Bank deposits 10.0k NOK → 22 NOK (-99.8% YoY). Calculated
Things to notice
-
·
COGS fell
COGS / varekostnad 81.65m NOK → 17 NOK (-100.0% YoY). Calculated
-
·
Book investments changed
Investment / intangible book value 0 NOK → 145.5k NOK. Reported fact